Depletion of the RNA binding protein HNRNPD impairs homologous recombination by inhibiting DNA-end resection and inducing R-loop accumulation.
Antineoplastic Agents
/ pharmacology
Camptothecin
/ pharmacology
Checkpoint Kinase 1
/ genetics
Chromatin
/ drug effects
DNA
/ drug effects
DNA Breaks, Double-Stranded
/ drug effects
DNA End-Joining Repair
/ drug effects
DNA, Single-Stranded
/ genetics
Genome, Human
Genomic Instability
HeLa Cells
Heterogeneous Nuclear Ribonucleoprotein D0
Heterogeneous-Nuclear Ribonucleoprotein D
/ antagonists & inhibitors
Heterogeneous-Nuclear Ribonucleoprotein U
/ genetics
Histones
/ genetics
Humans
Nucleic Acid Conformation
Nucleic Acid Hybridization
/ drug effects
Phosphorylation
/ drug effects
Phthalazines
/ pharmacology
Piperazines
/ pharmacology
RNA Polymerase II
/ genetics
RNA, Small Interfering
/ genetics
Recombinational DNA Repair
/ drug effects
Replication Protein A
/ genetics
Ribonuclease H
/ genetics
Journal
Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011
Informations de publication
Date de publication:
07 05 2019
07 05 2019
Historique:
accepted:
01
02
2019
revised:
24
01
2019
received:
08
08
2018
pubmed:
26
2
2019
medline:
26
11
2019
entrez:
26
2
2019
Statut:
ppublish
Résumé
DNA double strand break (DSB) repair through homologous recombination (HR) is crucial to maintain genome stability. DSB resection generates a single strand DNA intermediate, which is crucial for the HR process. We used a synthetic DNA structure, mimicking a resection intermediate, as a bait to identify proteins involved in this process. Among these, LC/MS analysis identified the RNA binding protein, HNRNPD. We found that HNRNPD binds chromatin, although this binding occurred independently of DNA damage. However, upon damage, HNRNPD re-localized to γH2Ax foci and its silencing impaired CHK1 S345 phosphorylation and the DNA end resection process. Indeed, HNRNPD silencing reduced: the ssDNA fraction upon camptothecin treatment; AsiSI-induced DSB resection; and RPA32 S4/8 phosphorylation. CRISPR/Cas9-mediated HNRNPD knockout impaired in vitro DNA resection and sensitized cells to camptothecin and olaparib treatment. We found that HNRNPD interacts with the heterogeneous nuclear ribonucleoprotein SAF-A previously associated with DNA damage repair. HNRNPD depletion resulted in an increased amount of RNA:DNA hybrids upon DNA damage. Both the expression of RNase H1 and RNA pol II inhibition recovered the ability to phosphorylate RPA32 S4/8 in HNRNPD knockout cells upon DNA damage, suggesting that RNA:DNA hybrid resolution likely rescues the defective DNA damage response of HNRNPD-depleted cells.
Identifiants
pubmed: 30799487
pii: 5364135
doi: 10.1093/nar/gkz076
pmc: PMC6486545
doi:
Substances chimiques
Antineoplastic Agents
0
Chromatin
0
DNA, Single-Stranded
0
H2AX protein, human
0
HNRNPD protein, human
0
HNRNPU protein, human
0
Heterogeneous Nuclear Ribonucleoprotein D0
0
Heterogeneous-Nuclear Ribonucleoprotein D
0
Heterogeneous-Nuclear Ribonucleoprotein U
0
Histones
0
Phthalazines
0
Piperazines
0
RNA, Small Interfering
0
Replication Protein A
0
DNA
9007-49-2
CHEK1 protein, human
EC 2.7.11.1
Checkpoint Kinase 1
EC 2.7.11.1
RNA Polymerase II
EC 2.7.7.-
RPA2 protein, human
EC 2.7.7.7
Ribonuclease H
EC 3.1.26.4
ribonuclease HI
EC 3.1.26.4
olaparib
WOH1JD9AR8
Camptothecin
XT3Z54Z28A
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4068-4085Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.
Références
Methods Mol Biol. 2006;314:123-31
pubmed: 16673879
Nature. 2007 Nov 22;450(7169):509-14
pubmed: 17965729
DNA Repair (Amst). 2014 Jul;19:84-94
pubmed: 24746923
Nature. 2009 Oct 22;461(7267):1071-8
pubmed: 19847258
EMBO J. 2008 Jul 9;27(13):1875-85
pubmed: 18511906
EMBO Rep. 2009 Aug;10(8):887-93
pubmed: 19557000
Int J Cell Biol. 2013;2013:153634
pubmed: 24159334
Nucleic Acids Res. 2008 Oct;36(17):5678-94
pubmed: 18772227
EMBO J. 2010 Apr 21;29(8):1446-57
pubmed: 20360682
Nucleic Acids Res. 2016 Jan 4;44(D1):D447-56
pubmed: 26527722
Nat Commun. 2015 Jul 28;6:7744
pubmed: 26215093
Nucleic Acids Res. 2013 Oct;41(19):9117-28
pubmed: 23935072
J Biol Chem. 1994 Apr 15;269(15):11121-32
pubmed: 8157639
Mol Cell. 2013 May 23;50(4):589-600
pubmed: 23706822
Mol Cell. 2007 Jan 12;25(1):71-83
pubmed: 17218272
Cytometry A. 2012 Oct;81(10):922-8
pubmed: 22893507
Cell Rep. 2018 May 8;23(6):1891-1905
pubmed: 29742442
Nature. 2000 Jun 8;405(6787):697-700
pubmed: 10864328
Annu Rev Biochem. 2008;77:229-57
pubmed: 18275380
J Biol Chem. 2015 Sep 18;290(38):22931-8
pubmed: 26231213
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Mol Oncol. 2011 Aug;5(4):387-93
pubmed: 21821475
J Biol Chem. 2010 Dec 31;285(53):41993-2000
pubmed: 20929861
Genes Dev. 2011 Feb 15;25(4):350-62
pubmed: 21325134
J Biol Chem. 2008 Jan 4;283(1):1-5
pubmed: 17999957
Int J Mol Sci. 2016 Feb 27;17(3):310
pubmed: 26927092
Mol Cell. 2012 Jul 13;47(1):5-15
pubmed: 22633954
Cancer Res. 2006 Aug 15;66(16):8109-15
pubmed: 16912188
Nat Rev Mol Cell Biol. 2014 Nov;15(11):749-60
pubmed: 25269475
Mol Cell Biol. 2008 May;28(9):3058-69
pubmed: 18285453
Genes Dev. 2014 Jul 1;28(13):1384-96
pubmed: 24990962
Cell. 2016 Nov 3;167(4):1001-1013.e7
pubmed: 27881299
Nature. 2001 Aug 9;412(6847):607-14
pubmed: 11493912
Genes Dev. 2011 Mar 1;25(5):409-33
pubmed: 21363960
J Mol Biol. 2017 Oct 27;429(21):3132-3138
pubmed: 27452366
Nucleic Acids Res. 2016 Jul 8;44(12):5743-57
pubmed: 27131361
Genes Dev. 1999 Oct 15;13(20):2633-8
pubmed: 10541549
Bioorg Med Chem Lett. 2017 Feb 15;27(4):701-707
pubmed: 28073672
Biomaterials. 2015 Sep;63:168-76
pubmed: 26107993
Nat Protoc. 2011 Feb;6(2):134-9
pubmed: 21293454
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5779-84
pubmed: 25902524
J Biol Chem. 2003 May 30;278(22):20303-12
pubmed: 12660252
Acta Neuropathol. 2013 Mar;125(3):413-23
pubmed: 23381195
J Biol Chem. 1985 Nov 25;260(27):14873-8
pubmed: 2997227
Genes Dev. 1998 Dec 15;12(24):3831-42
pubmed: 9869637
Methods Enzymol. 2006;409:118-31
pubmed: 16793398
Nucleic Acids Res. 2014 Aug;42(14):9047-62
pubmed: 25030905
J Biol Chem. 2005 May 13;280(19):18862-70
pubmed: 15734733
Nature. 2011 Mar 24;471(7339):532-6
pubmed: 21399625
Annu Rev Genet. 2004;38:233-71
pubmed: 15568977
Carcinogenesis. 2001 Nov;22(11):1789-96
pubmed: 11698340
Mol Cell Biol. 2016 Oct 28;36(22):2794-2810
pubmed: 27550810
Wiley Interdiscip Rev RNA. 2010 Nov-Dec;1(3):457-73
pubmed: 21956942
Cell Rep. 2017 Oct 10;21(2):324-332
pubmed: 29020620
Nat Commun. 2014 Nov 04;5:5248
pubmed: 25366541
Rejuvenation Res. 2009 Jun;12(3):199-208
pubmed: 19594328
Mol Cell. 2016 Oct 6;64(1):189-198
pubmed: 27716483
Cell Rep. 2014 Oct 23;9(2):451-9
pubmed: 25310973
Clin Oncol (R Coll Radiol). 2014 May;26(5):243-9
pubmed: 24630811
Genetics. 1998 Mar;148(3):989-1005
pubmed: 9539419
Front Biosci (Landmark Ed). 2011 Jun 01;16:2307-25
pubmed: 21622178
Mol Cell. 2010 Oct 22;40(2):179-204
pubmed: 20965415
Nat Rev Cancer. 2004 Oct;4(10):814-9
pubmed: 15510162
Nat Commun. 2018 Feb 7;9(1):532
pubmed: 29416038
J Biol Chem. 2009 Apr 3;284(14):9558-65
pubmed: 19202191
Crit Rev Biochem Mol Biol. 2016 May-Jun;51(3):195-212
pubmed: 27098756
Mol Cell. 2014 Jan 23;53(2):235-246
pubmed: 24332808
Mol Cell. 2012 Feb 24;45(4):505-16
pubmed: 22365830
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Mol Cell Biol. 2005 Aug;25(16):7158-69
pubmed: 16055725
Nat Cell Biol. 2016 Mar;18(3):271-280
pubmed: 26807646
J Biol Chem. 2008 Jul 4;283(27):19095-111
pubmed: 18469000
Nat Rev Mol Cell Biol. 2011 Feb;12(2):90-103
pubmed: 21252998
Biochim Biophys Acta. 2013 Jun-Jul;1829(6-7):680-8
pubmed: 23246978
Nucleic Acids Res. 2014 Feb;42(3):e19
pubmed: 24362840
Nat Rev Mol Cell Biol. 2002 Mar;3(3):195-205
pubmed: 11994740
Ann N Y Acad Sci. 2000;922:1-10
pubmed: 11193884
Nat Struct Mol Biol. 2010 Jan;17(1):11-6
pubmed: 20051983
DNA Repair (Amst). 2014 Jul;19:169-75
pubmed: 24746645
J Biol Chem. 1995 Sep 22;270(38):22167-75
pubmed: 7673195